Staphylococcal fibrinogen-binding protein

Staphylococcal fibrinogen-binding proteins are a group of virulence factors produced by *Staphylococcus aureus* that enable the bacterium to bind to human fibrinogen and related plasma proteins. These proteins are critical for bacterial adhesion to host tissues, colonization, immune evasion through formation of a protective "fibrin shield," and dissemination during infection. The main members include clumping factors A and B (ClfA/ClfB), coagulase, extracellular fibrinogen-binding protein (Efb), Eap/Map, FbpA, von Willebrand factor binding protein (vWbp), and vhp. They belong primarily to two structural classes: 1. Cell wall–anchored adhesins such as ClfA/B use an N-terminal A domain with IgG-like subdomains that mediate high-affinity binding via a "dock-lock-latch" mechanism. 2. Secreted SERAMs like coagulase and Efb interact with unordered regions in their structure. These proteins play essential roles in pathogenesis by mediating direct attachment to damaged heart valves or implanted biomaterials (*e.g.*, prosthetic devices) as well as promoting aggregation within blood clots or wounds[3]. Their ability to bind multiple sites on the host's plasma proteins makes them attractive but challenging targets for anti-staphylococcal therapies—especially since they often have overlapping functions. No approved drugs currently target these molecules directly; however, structural studies have identified peptide antagonists capable of blocking key interactions such as ClfA-fibrinogen binding[5]. Research is ongoing into vaccines or inhibitors that could disrupt these interactions without impairing normal hemostasis. In summary: Staphylococcal fibrinogen-binding proteins are validated therapeutic targets due to their central role in *S. aureus* virulence but present significant challenges due to functional redundancy among family members and potential safety concerns if targeted therapeutically[3][5].

Other names

Clumping factor A (ClfA)Clumping factor B (ClfB)Extracellular fibrinogen-binding protein (Efb)CoagulaseEap (Extracellular adherence protein)FbpAMapvWbp (von Willebrand factor binding protein)vhp

potential mechanisms include inhibition of bacterial adhesion or disruption of the fibrinogen-protein interaction; experimental peptides have been shown to block binding